Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis-Reference-Cited by-同舟云学术

Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis

Published:2014-08 Issue:1 Volume:147 Page:103-112
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Niikura Naoki,Hayashi Naoki,Masuda Norikazu,Takashima Seiki,Nakamura Rikiya,Watanabe Ken-ichi,Kanbayashi Chizuko,Ishida Mayumi,Hozumi Yasuo,Tsuneizumi Michiko,Kondo Naoto,Naito Yoichi,Honda Yayoi,Matsui Akira,Fujisawa Tomomi,Oshitanai Risa,Yasojima Hiroyuki,Tokuda Yutaka,Saji Shigehira,Iwata Hiroji

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-014-3090-8.pdf

Reference31 articles.

1. Klos KJ, O’Neill BP (2004) Brain metastases. Neurologist 10(1):31–46. doi: 10.1097/01.nrl.0000106922.83090.7101.nrl.0000106922.83090.71

2. Frisk G, Svensson T, Backlund LM, Lidbrink E, Blomqvist P, Smedby KE (2012) Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden. Br J Cancer 106(11):1850–1853. doi: 10.1038/bjc.2012.163bjc2012163

3. Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13(6):1648–1655. doi: 10.1158/1078-0432.CCR-06-2478

4. Brufsky AM, Mayer M, Rugo HS, Kaufman PA, Tan-Chiu E, Tripathy D, Tudor IC, Wang LI, Brammer MG, Shing M, Yood MU, Yardley DA (2011) Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clin Cancer Res 17(14):4834–4843. doi: 10.1158/1078-0432.CCR-10-296217/14/4834

5. Crivellari D, Pagani O, Veronesi A, Lombardi D, Nole F, Thurlimann B, Hess D, Borner M, Bauer J, Martinelli G, Graffeo R, Sessa C, Goldhirsch A (2001) High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol 12(3):353–356

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anin vivoscreen identifies NAT10 as a master regulator of brain metastasis;2024-08-21

2. Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM);Breast Cancer;2024-08-12

3. Enhanced anti-tumor effects by combination of tucatinib and radiation in HER2-overexpressing human cancer cell lines;Cancer Cell International;2024-08-06

4. Comprehensive analysis of stereotactic Radiosurgery outcomes in triple-negative breast cancer patients with brain metastases: The influence of immunotherapy and prognostic factors;The Breast;2024-08

5. Palliative surgery versus non-surgery of the solitary metastatic lesion in De novo metastatic breast cancer: A SEER based study;Medicine;2024-06-21